NOT MEDICAL ADVICE. No information on this site should be considered medical advice. Research peptides are not intended for human consumption — in-vitro lab use only. Consult a physician prior to introducing anything into the human body.

Pinealon

A synthetic tripeptide from the Russian bioregulatory-peptide program, studied mainly in animal models for neuroprotective and cognitive effects.

Overview

Pinealon is a synthetic tripeptide developed within the Russian program of bioregulatory peptides associated with the St. Petersburg Institute of Bioregulation and Gerontology. It is distributed internationally as a research compound with proposed cognitive and neuroprotective activity. Most published work originates from Russian-language literature and from rodent models, with human data limited.

Mechanism

Pinealon is described as modulating neuronal metabolism and protecting neurons under stress. Proposed actions include attenuation of excitotoxic damage, support of synaptic plasticity, and effects on brain energy metabolism. The molecular details remain incompletely defined and rest largely on tissue-level and behavioral studies in rodents.

Dosing

No internationally standardized research dose exists. Published studies use species- and protocol-specific regimens, and supplier recommendations are not clinically validated.

  • Animal studies have typically used systemic administration, with intranasal use reported in some human contexts
  • Doses are generally reported on a per-kilogram basis in rodent work
  • Route, schedule, and purity should be confirmed with the supplier

Expected Effects

  • Improved learning and memory measures reported in aged and stressed rodent models
  • Neuroprotective outcomes in rodent models of hypoxia and excitotoxicity
  • Claims of broad cognitive enhancement in healthy humans are not supported by independent clinical trials

Side Effects & Tolerability

As with most bioregulatory peptides, systematic safety data are sparse. Russian clinical use is generally described as well tolerated, and no serious adverse events are documented in the accessible literature, but long-term safety and drug-interaction data are lacking.

Storage

Lyophilized peptide should be stored cold, dry, and protected from light. Reconstituted solutions should be aliquoted and kept refrigerated or frozen, avoiding repeated freeze-thaw cycles.

Related peptides